Interview

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Assetbase.io. What does your company do? What...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Once Sync Limited. What does your company do?...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Infinity Blockchain Labs. What does your...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on HoneyFi. What does your company do? What unique...

Quicken Loans wants in on the "Avengers." “Who is the most confident?” Quicken Loans' Chief Marketing Officer Casey Hurbis asks, weighing the company's alignment with Iron Man or Captain America. He ultimately settles on “Captain America. All American — we...

Nike Inc (NYSE: NKE) may have exited the golf equipment business, but the brand is still as relevant as ever in the sport. Nike emerged as the clear winner of the 2018 Masters Tournament from an endorsement standpoint, according to a study of the event's marketing impact.  Nike endorser...

In an attempt to separate itself from the crowd and pivot toward a more profitable business model, cannabis media company MassRoots Inc (OTC: MSRT) has filed with the SEC to introduce a cryptocurrency.  The digital currency is “aimed at encouraging key...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Tradagon. What does your company do? What unique...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Yellow Card. What does your company do? What...

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is taking on a broad list of indications with RNAi therapeutics, from bleeding disorders to hypercholesterolemia to amyloidosis. “We’re really building a company that can emerge as a top five biotech company over the next five or so years,...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on HomeZada. What does your company do? John...

The Benzinga Global Fintech Awards are a yearly showcase of the best and brightest in fintech. In preparation for its biggest installment yet in May 2018, we're profiling the companies competing for the BZ Awards. Our next feature is on Omega Grid. What does your company do? What...

Two words summarize last week’s most relevant event for the cannabis industry: John Boehner. The former House speaker announced his views on cannabis had evolved and, in support of legalization, he was joining the board of directors of New York-based marijuana company Acreage Holdings. To...

Ziopharm Oncology Inc. (NASDAQ: ZIOP) has two goals. One is to disrupt the narrative around recurrent glioblastomas. The other is to disrupt the entire pharmaceutical supply chain. The latter pursuit isn’t just a B2B revenue opportunity, it's meant to alleviate cost barriers to critical...